(Q66035116)
Statements
Gemtuzumab Ozogamicin (CMA-676) Followed or Not by Intensive Chemotherapy as Initial Treatment for Elderly Patients With Acute Myeloid Leukemia: An EORTC-LG Pilot Phase II Study (English)
0 references
June 2000
0 references
January 2002
0 references
106
0 references
61 year
0 references